Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report

Fig. 1

The clinical progress of Histobulin™ therapy in CSU. a Clinical progress. b Five steps of clinical progress in Histobulin™ therapy: initial improvement (initial improvement), reduction in medication frequency per week (medication reduction), cessation of medication (medication free) without the symptoms and signs of CSU, free of symptoms without medication (symptom free) and persistence of symptom-free status for more than 4 weeks without any medication or treatment (remission)

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us